PBI-1737

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePBI-1737
Drug Alias NameTNF alpha inhibitors (ProMetic)series III compounds (ProMetic)series 3 compounds (ProMetic)PBI-1522PBI-1736 +[6] 
ClassificationSmall molecules
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLiminal Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLiminal Biosciences Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A